BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/23/2014 6:47:00 PM | Browse: 1175 | Download: 1141
 |
Received |
|
2013-12-18 10:11 |
 |
Peer-Review Started |
|
2013-12-18 15:47 |
 |
To Make the First Decision |
|
2014-01-16 08:31 |
 |
Return for Revision |
|
2014-01-26 16:20 |
 |
Revised |
|
2014-01-29 03:48 |
 |
Second Decision |
|
2014-06-16 13:55 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-06-16 14:04 |
 |
Articles in Press |
|
2014-06-16 14:42 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-08-28 13:58 |
 |
Publish the Manuscript Online |
|
2014-09-17 14:32 |
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Topic Highlights |
Article Title |
Prehypertension: Underlying pathology and therapeutic options
|
Manuscript Source |
Invited Manuscript |
All Author List |
Sulayma Albarwani, Sultan Al-Siyabi and Musbah O Tanira |
Funding Agency and Grant Number |
|
Corresponding Author |
Dr. Sulayma Albarwani, Department of Physiology, College of Medicine and Health Sciences, Sultan Qaboos University, P.O.Box 35, Muscat 123,
Oman. salbarwani@squ.edu.om
|
Key Words |
Prehypertension; Renin-angiotensin system; Therapeutic lifestyle changes; Polypill |
Core Tip |
There is a current debate over the ideal means of intervening in prehypertension. Since it is the cardiovascular risk that constitute the basis for intervention in both prehypertension and hypertension, the review discusses the following points, that: (1) categorizing blood pressure levels is based on mere 20 mmHg brackets; hence this doctrine may be re-visited to include other cardiovascular risk factors to categorize patients regardless of their blood pressure level; (2) investigating the therapeutic potential of intervening in all pathophysiological processes associated with prehypertension; and (3) ascertaining the therapeutic value of the “Polypill” in prehypertensives as means of primary prevention.
|
Publish Date |
2014-09-17 14:32 |
Citation |
Albarwani S, Al-Siyabi S, Tanira MO. Prehypertension: Underlying pathology and therapeutic options. World J Cardiol 2014; 6(8): 728-743 |
URL |
http://www.wjgnet.com/1949-8462/full/v6/i8/728.htm |
DOI |
http://dx.doi.org/10.4330/wjc.v6.i8.728 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345